RxDoctor Payments Data
★ My doctorsLook up a doctor →

Jeffrey Davis

Adolescent Medicine · Holiday, FLNPI 1538165428

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.5% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $963 and has fallen 98.3% since, to $16 in 2025. Among adolescent medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,495in general payments, 2019–2025

Across 143 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$419
  • Johnson & Johnson$281
  • Novartis$269
  • Boehringer Ingelheim$202
  • Amgen$179
  • Bayer$169
  • plus $975 from 16 others

What the payments were for

  • Food & beverage$2,38396%
  • Education$1114%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk24$419
Johnson & Johnson20$281
Novartis16$269
Boehringer Ingelheim9$202
Amgen11$179
Bayer8$169
GSK10$152
AstraZeneca9$144
Astellas Pharma US Inc3$133
Lilly USA, LLC6$98
Kowa Pharmaceuticals America, Inc.7$93
Dexcom, Inc.5$80
Amarin Pharma, Inc.3$71
Pfizer3$51
E.r. Squibb & Sons, L.L.C.2$32
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$24
Biohaven Pharmaceuticals, Inc.1$21
Merck1$17
Biogen1$16
Telix Pharmaceuticals1$16
CSL Behring1$13
Sanofi Pasteur Inc.1$12

How this compares

$2,495 in reported general payments places this provider in the 90th percentile of 113 adolescent medicine providers in Florida.

See all adolescent medicine providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$17,873
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$541
Rosuvastatin Calcium17$441
Duloxetine Hcl22$277
Losartan Potassium18$169
Pantoprazole Sodium12$156
Gabapentin14$143
Pravastatin Sodium14$131
Levothyroxine Sodium15$130
Amlodipine Besylate40$129
Atorvastatin Calcium31$112
Lisinopril16$82
Doxepin Hcl13$67

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$51$17,87315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 113 adolescent medicine providers in Florida.

Other adolescent medicine in Holiday

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →